當前位置：首頁 SCI期刊 SCIE期刊生物學中科院3區(qū) JCRQ1 期刊介紹(非官網(wǎng))

Artificial Cells Nanomedicine And BiotechnologySCIE

國際簡稱：ARTIF CELL NANOMED B 參考譯名：人工細胞納米醫(yī)學與生物技術

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：2169-1401; E-ISSN：2169-141X; 是否OA：未開放; 是否預警：是; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Informa Healthcare; 出版語言：English; 出版周期：1 issue/year; 出版年份：2013; 研究方向：ENGINEERING, BIOMEDICAL-BIOTECHNOLOGY & APPLIED MICROBIOLOGY

評價信息：: 影響因子：4.5; H-index：35; CiteScore指數(shù)：10.9; SJR指數(shù)：0.646; SNIP指數(shù)：0.903

發(fā)文數(shù)據(jù)：: Gold OA文章占比：98.61%; 研究類文章占比：90.57%; 年發(fā)文量：53; 自引率：0; 開源占比：0.9865; 出版撤稿占比：0.1759...; 出版國人文章占比：0.46; OA被引用占比：0.4587...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Artificial Cells Nanomedicine And Biotechnology期刊介紹

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.

期刊簡介Artificial Cells Nanomedicine And Biotechnology期刊介紹

《Artificial Cells Nanomedicine And Biotechnology》自2013出版以來，是一本生物學優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結果，并為生物學各個領域的原創(chuàng)研究提供一個展示平臺，以促進生物學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領域的所有重要發(fā)展。該期刊特色在于及時報道生物學領域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年被列入預警期刊名單，目前已被權威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間： 20 Weeks
生物學
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
中科院3區(qū)
預警

Cite Score數(shù)據(jù)（2024年最新版）Artificial Cells Nanomedicine And Biotechnology Cite Score數(shù)據(jù)

CiteScore：10.9
SJR：0.646
SNIP：0.903

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Medicine (miscellaneous)	Q1	29 / 398	92%
大類：Medicine 小類：Pharmaceutical Science	Q1	14 / 183	92%
大類：Medicine 小類：Biomedical Engineering	Q1	36 / 303	88%
大類：Medicine 小類：Biotechnology	Q1	40 / 311	87%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Artificial Cells Nanomedicine And Biotechnology 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
生物學	3區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應用微生物 ENGINEERING, BIOMEDICAL 工程：生物醫(yī)學 MATERIALS SCIENCE, BIOMATERIALS 材料科學：生物材料	3區(qū) 3區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎，運用科學計量學方法對國際、國內(nèi)學術期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Artificial Cells Nanomedicine And Biotechnology JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	34 / 174	80.7%
學科：ENGINEERING, BIOMEDICAL	SCIE	Q2	35 / 122	71.7%
學科：MATERIALS SCIENCE, BIOMATERIALS	SCIE	Q2	22 / 53	59.4%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q1	34 / 174	80.75%
學科：ENGINEERING, BIOMEDICAL	SCIE	Q2	31 / 122	75%
學科：MATERIALS SCIENCE, BIOMATERIALS	SCIE	Q2	14 / 53	74.53%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術文獻質(zhì)量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
CHINA MAINLAND647
Iran206
India144
USA66
South Korea42
Saudi Arabia35
Turkey26
Pakistan25
Egypt16
Malaysia16

本刊中國學者近年發(fā)表論文

1、The Rhei radix rhizoma-based carbon dots ameliorates dextran sodium sulphate-induced ulcerative colitis in mice
Author: Zhang, Yifan; Zhao, Jie; Zhao, Yusheng; Bai, Xue; Chen, Yumin; Liu, Yuhan; Zhang, Yue; Kong, Hui; Qu, Huihua; Zhao, Yan

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 180-191. DOI: 10.1080/21691401.2023.2197947
2、a-Lipoic acid loaded hollow gold nanoparticles designed for osteoporosis treatment: preparation, characterization and in vitro evaluation
Author: Xi, Yanhai; Pan, Wenming; Liu, Yanyan; Liu, Ji; Xu, Guohua; Su, Yanguo; Chen, Daquan; Ye, Xiaojian

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 131-138. DOI: 10.1080/21691401.2022.2149542
3、Simple and feasible detection of hepatitis a virus using reverse transcription multienzyme isothermal rapid amplification and lateral flow dipsticks without standard PCR laboratory
Author: Sun, Mao-ling; Zhong, Yang; Li, Xiao-na; Yao, Jun; Pan, Yu-qing

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 233-240. DOI: 10.1080/21691401.2023.2203198
4、Identification of stemness subtypes and features to improve endometrial cancer treatment using machine learning
Author: Lu, Xiaoqin; Ying, Yanqi; Zhang, Wenyi; Li, Rui; Wang, Wuliang

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 57-73. DOI: 10.1080/21691401.2023.2172027
5、PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
Author: Li, Bingting; Zhang, Jun; Ma, Ning; Li, Weidan; You, Guoxing; Chen, Gan; Zhao, Lian; Wang, Quan; Zhou, Hong

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 120-130. DOI: 10.1080/21691401.2023.2176865
6、Novel dual CAFs and tumour cell targeting pH and ROS dual sensitive micelles for targeting delivery of paclitaxel to liver cancer
Author: Guo, Chunjing; Zhang, Wei; Zhang, Qiaoyun; Su, Yanguo; Hou, Xiaoya; Chen, Qiang; Guo, Huimin; Kong, Ming; Chen, Daquan

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 170-179. DOI: 10.1080/21691401.2023.2193221
7、Exploration of effective biomarkers and infiltrating Immune cells in Osteoarthritis based on bioinformatics analysis
Author: Cheng, Piaotao; Gong, Shouhang; Guo, Caopei; Kong, Ping; Li, Chencheng; Yang, Chengbing; Zhang, Tao; Peng, Jiachen

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 242-254. DOI: 10.1080/21691401.2023.2185627
8、A novel PDT: 5-aminolevulinic acid combined 450 nm blue laser photodynamic therapy significantly promotes cell death of HR-HPV infected cells
Author: Chen, Yuqing; Mei, Yibo; Gu, Lijiang; Li, Xing; Guo, Peng; Chen, Lihong; He, Dalin

Journal: ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY. 2023; Vol. 51, Issue 1, pp. 22-32. DOI: 10.1080/21691401.2022.2164585